
Opinion|Videos|October 29, 2024
Study Objectives and Key Inclusion Criteria for GPP Patients
Key Takeaways
Delve into the complexities of generalized pustular psoriasis (GPP), a rare and life-threatening skin condition, and explore how the monoclonal antibody spesolimab is being investigated to prevent severe, unpredictable flares.
Advertisement
Episodes in this series

Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
The “6-7” Advances for Dermatologists to Look Forward to in 2026
2
Quoin Targets World’s First Approval for Netherton Syndrome Therapy in Saudi Arabia
3
Obagi Launches ALOHA Program to Capture Real-World Insights in Aesthetic Injectables
4
Exploring Type 2 Inflammation and Psoriasis Management at Horizons in Advanced Practice
5

















